ECT and onset of action

Journal of Clinical Psychiatry

Volumn 62, Issue SUPPL. 4, 2001, Pages 24-26

  Roose, S P ^a   Nobler, M ^a  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; FLUOXETINE; HYPNOTIC AGENT;

ARTICLE; DATA ANALYSIS; DEPRESSION; DISEASE SEVERITY; DRUG EFFECT; DRUG EFFICACY; ELECTROCONVULSIVE THERAPY; HUMAN; INTERMETHOD COMPARISON; LATENT PERIOD; MEDICAL RESEARCH; METHODOLOGY; OUTCOMES RESEARCH; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; SCORING SYSTEM; TREATMENT OUTCOME;

ANTIDEPRESSIVE AGENTS; CLINICAL TRIALS; COMBINED MODALITY THERAPY; DEPRESSIVE DISORDER; ELECTROCONVULSIVE THERAPY; HUMANS; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 0035116565     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (4)

1. What constitutes an adequate antidepressant trial for fluoxetine?
2. Effect of dose escalation after low-dose fluoxetine therapy
3. Onset and time course of antidepressant action: Psychopharmacological implications of a controlled trial of electroconvulsive therapy
4. Quantifying the speed of symptomatic improvement with electroconvulsive therapy: Comparison of alternative statistical methods